Novartis India's Stocks Fall after Nine Sessions of Increase; Stocks Up by 52% since August 31

5paisa Capital Ltd - 0 min read

Last Updated: 11th September 2026 - 04:47 pm

Shares of Novartis India fell on September 11, marking the end of nine days of rallies during which the stocks had risen 52% from August 31. 

At the start of the day, the stocks made positive moves but fell back later. The stocks rose to ₹2,550, which is a 5% rise. As the day progressed, the stocks fell back, with Novartis India ending the day down 1.16% at ₹2,400. 

Recent Rally Followed Trademark Acquisition 

Much of the recent buying came after the company’s September 7 disclosure regarding the acquisition of the “Minipress” and “Minipres” trademarks. 

Novartis India’s board approved the acquisition of the trademarks registered in India, along with certain related intellectual property rights, from Pfizer Inc USA and Pfizer Products Inc USA. 

The transaction carries an aggregate consideration of ₹1,250 crore. 

On the same day as the board approval, Novartis India entered into an asset purchase agreement and trademark assignment deeds with the two Pfizer entities to take the transaction forward. 

The development had been followed by a sharp run in the stock. From August 31 through the nine-session rally, Novartis India shares gained 52% before giving up ground on September 11. 

FREE Trading & Demat Account
Open FREE Demat Account with endless opportunities.
  • Flat ₹20 Brokerage
  • Next-gen Trading
  • Advanced Charting
  • Actionable Ideas
+91
''
By proceeding, you agree to our T&Cs*
Mobile No. belongs to
OR
hero_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form